Utilizing Linked Color Imaging for the Identification and Assessment of Gastrointestinal Neuroendocrine Tumors - Scorecard - MDSpire

Utilizing Linked Color Imaging for the Identification and Assessment of Gastrointestinal Neuroendocrine Tumors

  • By

  • Xin Pu

  • Yang Xu

  • Xueting Zhang

  • Zijin Yin

  • Yan Liu

  • Min Min

  • November 5, 2025

  • 0 min

Share

Clinical Scorecard: Utilizing Linked Color Imaging for the Identification and Assessment of Gastrointestinal Neuroendocrine Tumors

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients diagnosed with GI-NETs between January 2016 and March 2024 (ensure accuracy).
Care Setting

Key Highlights

  • additional_metrics

Guideline-Based Recommendations

Diagnosis

    Management

    • I
    • n
    • c
    • l
    • u
    • d
    • e
    • s
    • p
    • e
    • c
    • i
    • f
    • i
    • c
    • f
    • o
    • l
    • l
    • o
    • w
    • -
    • u
    • p
    • p
    • r
    • o
    • t
    • o
    • c
    • o
    • l
    • s
    • f
    • o
    • r
    • p
    • a
    • t
    • i
    • e
    • n
    • t
    • s
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Patients with diagnosed GI-NETs, particularly those with small lesions.

        Early detection through LCI may improve treatment outcomes.

        Clinical Best Practices

        • training

        References

        Original Source(s)

        Related Content